Cell News and Research

RSS

Physicians to provide high-quality care, training to medically underserved community

Today, the first class of Texas Children's Global Health Corps will depart Houston for assignment in Africa. This talented team of pediatricians and family doctors will provide medical care and treatment to thousands of children and families affected by serious or life-threatening medical conditions, including sickle cell disease, malaria, tuberculosis, malnutrition, cancer and HIV/AIDS.

30 Jul 2011

Researchers examine drug that has potential to stop Parkinson's progression

Researchers from Michigan State University's College of Human Medicine, Van Andel Research Institute and the Translational Genomics Research Institute are investigating a drug that has the potential to not only alleviate Parkinson's symptoms but also halt the disease's progression.

30 Jul 2011

Researchers awarded $12M to study pathology of severe lung injury

Researchers at the University of Illinois at Chicago College of Medicine have been awarded more than $11.7 million to study the pathology of severe lung injury.

30 Jul 2011

EGT transfers clinical grade lentiviral vector to MSKCC

Errant Gene Therapeutics, LLC, a pioneering boutique drug development firm specializing in Rare Diseases, announced the transfer of its clinical grade lentiviral vector, TNS 9.55.3, to Memorial Sloan Kettering Cancer Center.

29 Jul 2011

Anthera reports increase in second quarter total operating expenses to $22.7 million

Anthera Pharmaceuticals, Inc., today announced financial results and business highlights for the quarter ended June 30, 2011.

29 Jul 2011

Amgen reports 8% increase in second quarter total product sales to $3,893 million

Amgen reported total revenue increased 4 percent during the second quarter of 2011 to $3,959 million versus $3,804 million in the second quarter of 2010. Total product sales increased 8 percent in the second quarter of 2011 to $3,893 million versus $3,613 million in the second quarter of 2010. The increase in total revenue in the second quarter of 2011 included a decline in other revenue due to certain milestone payments earned in the second quarter of 2010.

29 Jul 2011

Human kinome RNAi screening performed using Roche’s xCELLigence MP Instrument

RNA interference studies are a powerful technology for high-throughput screening. However, endpoint analyses only provide a snapshot of the analyzed cellular phenotype, as it is not possible to measure developmental changes over time.

29 Jul 2011

Studies reveal new set of mutations linked with head and neck cancer

Powerful new technologies that zoom in on the connections between human genes and diseases have illuminated the landscape of cancer, singling out changes in tumor DNA that drive the development of certain types of malignancies such as melanoma or ovarian cancer.

29 Jul 2011

New protein discovery could help develop intracellular biologic drugs

Permeon Biologics, a biopharmaceutical company pioneering a novel class of intracellular protein biologics, today announced the discovery of an entirely new class of naturally occurring human supercharged proteins called Intraphilins-.

29 Jul 2011

Customized surfaces help reveal protein clumping process linked with Alzheimer's, diabetes

When normal proteins form protein clumps in the body, then alarm bells start ringing. Such clumps, called "amyloids," are closely associated with Alzheimer's disease and type 2 diabetes, formerly called adult-onset diabetes.

29 Jul 2011

Federal judge upholds Obama rule on stem cell research

A U.S. judge Wednesday upheld the government rules that allow federal funding of human embryonic stem cell research that might lead to cures for deadly diseases affecting millions of Americans.

29 Jul 2011

Grapes help protect skin cells from sun's UV radiation

Some compounds found in grapes help to protect skin cells from the sun's ultraviolet radiation, according to a study by researchers from the University of Barcelona and the CSIC.

29 Jul 2011

New early warning system could avert bridge disasters

Millions of U.S. drivers cross faulty or obsolete bridges every day, highway statistics show, but it's too costly to fix all these spans or adequately monitor their safety, says a University of Maryland researcher who's developed a new, affordable early warning system.

29 Jul 2011

Cancer Research UK honors cell signalling expert with Lifetime Achievement Prize

Professor Chris Marshall has been named as the recipient of this year's Cancer Research UK Lifetime Achievement Prize.

29 Jul 2011

Introducing maspin protein into tumor nucleus can stop growth and spread of cancer

According to the Canadian Cancer Society, one in four Canadians will die of cancer. This year alone, the disease will kill an estimated 75,000 people. With incidence rates on the rise, more cancer patients are facing grave prognoses.

29 Jul 2011

Scientist discovers novel way to convert human skin cells into neurons

A scientist at the Gladstone Institutes has discovered a novel way to convert human skin cells into brain cells, advancing medicine and human health by offering new hope for regenerative medicine and personalized drug discovery and development.

29 Jul 2011

Polaris initiates ADI-PEG 20 Phase 3 trial in hepatocellular carcinoma

Polaris Group today announced that it has dosed the first patient in a pivotal Phase 3 clinical trial evaluating its lead cancer therapeutic, pegylated arginine deiminase (ADI-PEG 20), in hepatocellular carcinoma (HCC) patients.

29 Jul 2011

Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe

Soligenix, Inc., a late-stage biopharmaceutical company, announces the expansion and amendment of its North American licensing partnership with Sigma-Tau Pharmaceuticals, Inc. for the development and commercialization of orBec into the European territory.

29 Jul 2011

Positive data from Histogenics' NeoCart Phase 2 study on knee cartilage injury

Histogenics Corporation, a privately held regenerative medicine company, today announced the presentation of positive Phase 2 data for the NeoCart Autologous Cartilage Tissue Implant.

29 Jul 2011

Drug to prevent brain ageing: Study

A new study shows that some chemicals given to rhesus macaques blocked a brain molecule that slows the firing of the brain's nerve cells, or neurons, as they age—prompting those nerve cells to act young again.

28 Jul 2011

Cell News and Research

Physicians to provide high-quality care, training to medically underserved community

Researchers examine drug that has potential to stop Parkinson's progression

Researchers awarded $12M to study pathology of severe lung injury

EGT transfers clinical grade lentiviral vector to MSKCC

Anthera reports increase in second quarter total operating expenses to $22.7 million

Amgen reports 8% increase in second quarter total product sales to $3,893 million

Human kinome RNAi screening performed using Roche’s xCELLigence MP Instrument

Studies reveal new set of mutations linked with head and neck cancer

New protein discovery could help develop intracellular biologic drugs

Customized surfaces help reveal protein clumping process linked with Alzheimer's, diabetes

Federal judge upholds Obama rule on stem cell research

Grapes help protect skin cells from sun's UV radiation

New early warning system could avert bridge disasters

Cancer Research UK honors cell signalling expert with Lifetime Achievement Prize

Introducing maspin protein into tumor nucleus can stop growth and spread of cancer

Scientist discovers novel way to convert human skin cells into neurons

Polaris initiates ADI-PEG 20 Phase 3 trial in hepatocellular carcinoma

Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe

Positive data from Histogenics' NeoCart Phase 2 study on knee cartilage injury

Drug to prevent brain ageing: Study

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News